BROUGHT TO YOU BY:
TORONTO, Dec. 23, 2019 /HalcyonTV/ - National Access Cannabis Corp. (TSXV: META) d/b/a Meta Growth ("Meta Growth", "META" or the "Company"), Canada's largest publicly traded recreational cannabis retailer by revenue1, today announced its financial results for the fourth quarter and fiscal year ended August 31, 2019. All amounts are expressed in Canadian dollars.
Q4 2019 Financial Highlights
For a more comprehensive overview of the financial highlights presented in this press release, please refer to Meta Growth's Audited Consolidated Financial Statements for the years ended August 31, 2019 and 2018, and the Company's Management Discussion and Analysis for the year ended August 31, 2019. Both of these documents are available on the Company's SEDAR profile at www.sedar.com.
There are measures included in this news release that do not have a standardized meaning prescribed by IFRS and therefore may not be comparable to similarly titled measures and metrics presented by other publicly traded companies. The Company includes these measures because it believes certain investors use these measures and metrics as a means of assessing financial performance. EBITDA (earnings before interest, taxes, depreciation and amortization) is a non-IFRS financial measure that does not have any standardized meaning prescribed by IFRS and may not be comparable to similar measures presented by other companies.
Industry leader Host Defense Mushrooms showcases excellence in research with new publication in high-impact, open access journal
OLYMPIA, Wash., Dec. 6, 2019 /HalcyonTV/ -- Fungi Perfecti, LLC (manufacturer of Host Defense® Mushrooms™) has partnered with third-party immunology experts at Natural Immune Systems, Inc. to investigate the health-enhancing benefits of mushroom mycelium and its fermented substrate. Together they have published new peer-reviewed research in the journal BMC Complementary and Alternative Medicine.
Read the new research at the following link: https://doi.org/10.1186/s12906-019-2681-7
Mushrooms are undergoing a tremendous surge in popularity, especially for use as dietary supplements in supporting immunity and overall health. Mushroom supplements may include ingredients from various parts of the mushroom lifecycle, such as mycelium, fruitbodies or spores.
When mushroom mycelium is grown for use in supplements, grains such as brown rice are commonly used as a food source. Mushroom mycelium digests the rice, increasing the mass of mycelium while reducing the presence of grain. During the growth process, the grain substrate becomes enmeshed with and inseparable from the mycelium. Removing what is left of the grain substrate is not practical at production scale, and so some fermented substrate is generally included with pure mycelium in mycelium-based mushroom supplements.
Because some fermented substrate remains in the final mycelium-based product, some distributors of mushroom ingredients have suggested that mycelium-based products are inactive or largely composed of fillers.
However, newly published peer-reviewed research in BMC Complementary and Alternative Medicine verifies that:
Co-author Paul Stamets notes, "In my scientific opinion, mushroom products not incorporating mycelium are at a decided disadvantage, given the results of recent research."
This research further validates mushroom mycelium, along with its fermented substrate, as a uniquely valuable and efficacious nutritional support for healthy immune functioning.
Beyond the conclusions of the research itself, the method of review and publication are noteworthy for being open and transparent to readers and the health industry in general.
In addition to providing open access to the final publication, BMC Complementary and Alternative Medicine creates further transparency through an open peer review process. This process includes:
This study once again confirms that not only the mycelium but the substrate on which it is grown becomes profoundly immune enhancing.
The full research article may be viewed in BMC Complementary and Alternative Medicine at the following link: https://doi.org/10.1186/s12906-019-2681-7
Paul Stamets & Fungi Perfecti, LLC:
Founder, owner and Chief Scientist of Fungi Perfecti, Paul Stamets has been recognized for decades as a leading innovator in the field of mycology, with a focus on revealing the health-supporting properties of mushrooms. As a renowned researcher and author of six books and numerous peer-reviewed scientific papers, Stamets' Host Defense® mushroom formulations have long been the most sought-after and highly valued within the dietary supplement industry.
SOURCE Fungi Perfecti, LLC